Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COAT: 5 vs 7 Days of Oral Flucloxacillin in Lower Limb Cellulitis
NCT05584007Phase 3Recruiting
- Sponsor
- University of Southampton
- Start
- Aug 2023
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of flucloxacillin in cellulitis (2 arms), sponsored by University of Southampton. Primary endpoint: Pain assessment. Started Aug 2023; status: recruiting.
02
Drugs
flucloxacillin
03
Conditions
cellulitis
Beyond the preview
Go deeper on NCT05584007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05584007.